chr5-35871171-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BA1BP7BS2_Supporting

This summary comes from the ClinGen Evidence Repository: The c.495C>T (p.His165=) variant (NM_002185.5) is a synonymous (silent) variant that is not predicted by SpliceAI and varSEAK to impact splicing (BP7).The filtering allele frequency (the lower threshold of the 95% CI of 5398/35384) of the c.495C>T variant in IL7R is 0.1491 for Latino/Admixed American chromosomes by gnomAD v2.1.1, which is higher than the ClinGen SCID VCEP threshold (>0.00566) for BA1, and therefore meets this criterion (BA1). Additionally, 2363 homozygous individuals were reported (BS2_Supporting is met).In summary, this variant is classified as Benign for autosomal recessive SCID based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): BP7, BA1, and BS2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA291241/MONDO:0012163/119

Frequency

Genomes: 𝑓 0.13 ( 1327 hom., cov: 33)
Exomes 𝑓: 0.13 ( 13845 hom. )

Consequence

IL7R
NM_002185.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: -0.446

Publications

31 publications found
Variant links:
Genes affected
IL7R (HGNC:6024): (interleukin 7 receptor) The protein encoded by this gene is a receptor for interleukin 7 (IL7). The function of this receptor requires the interleukin 2 receptor, gamma chain (IL2RG), which is a common gamma chain shared by the receptors of various cytokines, including interleukins 2, 4, 7, 9, and 15. This protein has been shown to play a critical role in V(D)J recombination during lymphocyte development. Defects in this gene may be associated with severe combined immunodeficiency (SCID). Alternatively spliced transcript variants have been found. [provided by RefSeq, Dec 2015]
IL7R Gene-Disease associations (from GenCC):
  • immunodeficiency 104
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7RNM_002185.5 linkc.495C>T p.His165His synonymous_variant Exon 4 of 8 ENST00000303115.8 NP_002176.2 P16871-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7RENST00000303115.8 linkc.495C>T p.His165His synonymous_variant Exon 4 of 8 1 NM_002185.5 ENSP00000306157.3 P16871-1
IL7RENST00000506850.5 linkc.495C>T p.His165His synonymous_variant Exon 4 of 6 2 ENSP00000421207.1 P16871-3
IL7RENST00000514217.5 linkn.495C>T non_coding_transcript_exon_variant Exon 4 of 6 2 ENSP00000427688.1 B8YG18

Frequencies

GnomAD3 genomes
AF:
0.132
AC:
19986
AN:
151976
Hom.:
1327
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.143
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.0632
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.146
GnomAD2 exomes
AF:
0.127
AC:
31804
AN:
251042
AF XY:
0.122
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.152
Gnomad ASJ exome
AF:
0.119
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.0991
Gnomad NFE exome
AF:
0.138
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.134
AC:
195901
AN:
1457346
Hom.:
13845
Cov.:
31
AF XY:
0.132
AC XY:
95373
AN XY:
725238
show subpopulations
African (AFR)
AF:
0.128
AC:
4264
AN:
33390
American (AMR)
AF:
0.154
AC:
6886
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
3117
AN:
26104
East Asian (EAS)
AF:
0.133
AC:
5283
AN:
39648
South Asian (SAS)
AF:
0.0614
AC:
5293
AN:
86212
European-Finnish (FIN)
AF:
0.100
AC:
5364
AN:
53396
Middle Eastern (MID)
AF:
0.140
AC:
806
AN:
5748
European-Non Finnish (NFE)
AF:
0.141
AC:
156724
AN:
1107898
Other (OTH)
AF:
0.136
AC:
8164
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
7361
14722
22082
29443
36804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5686
11372
17058
22744
28430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19978
AN:
152094
Hom.:
1327
Cov.:
33
AF XY:
0.128
AC XY:
9523
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.132
AC:
5464
AN:
41464
American (AMR)
AF:
0.143
AC:
2188
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
455
AN:
3472
East Asian (EAS)
AF:
0.145
AC:
747
AN:
5168
South Asian (SAS)
AF:
0.0624
AC:
301
AN:
4820
European-Finnish (FIN)
AF:
0.101
AC:
1069
AN:
10578
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.136
AC:
9278
AN:
67994
Other (OTH)
AF:
0.144
AC:
304
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
915
1830
2745
3660
4575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.138
Hom.:
1629
Bravo
AF:
0.139
Asia WGS
AF:
0.106
AC:
369
AN:
3478
EpiCase
AF:
0.140
EpiControl
AF:
0.139

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:3
Nov 16, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied by a panel of primary immunodeficiencies. Number of patients: 30. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Immunodeficiency 104 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 14, 2023
ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The c.495C>T (p.His165=) variant (NM_002185.5) is a synonymous (silent) variant that is not predicted by SpliceAI and varSEAK to impact splicing (BP7). The filtering allele frequency (the lower threshold of the 95% CI of 5398/35384) of the c.495C>T variant in IL7R is 0.1491 for Latino/Admixed American chromosomes by gnomAD v2.1.1, which is higher than the ClinGen SCID VCEP threshold (>0.00566) for BA1, and therefore meets this criterion (BA1). Additionally, 2363 homozygous individuals were reported (BS2_Supporting is met). In summary, this variant is classified as Benign for autosomal recessive SCID based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP (specification version 1.0): BP7, BA1, and BS2_Supporting. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.5
DANN
Benign
0.43
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228141; hg19: chr5-35871273; COSMIC: COSV57406213; COSMIC: COSV57406213; API